USA flag logo/image

An Official Website of the United States Government

Software Technology for QFT-GIT ELISA Reader

Award Information

Agency:
Department of Defense 		Branch:
Office of the Secretary of Defense 		Award ID:
83003 		Program Year/Program:
2007 / SBIR
Agency Tracking Number:
O063-H06-3142 		Solicitation Year:
N/A 		Solicitation Topic Code:
N/A 		Solicitation Number:
N/A
Small Business Information
Celadon Laboratories, Inc.
6525 Belcrest Rd Suite 521 Hyattsville, MD -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2007
Title: Software Technology for QFT-GIT ELISA Reader
Agency / Branch: DOD / OSD
Contract: FA8650-07-M-6720
Award Amount: $99,901.00
 

Abstract:

Tuberculosis is a growing threat to military personnel. The accepted method of preventing tuberculosis disease in military personnel is to screen for latent infection using the tuberculin skin test. In order to overcome the high false-positive and false-negative rates of the skin test, the Air Force is conducting a clinical trial of the Cellestis QFT-GIT test kit. The clinical trial presents the opportunity for a software system that manages and interprets QFT-GIT test data. The deliverable of this Phase 1 SBIR proposal is software that transforms optical density readings from the Triturus ELISA reader into QFT-GIT clinical results. It will communicate electronically with the Triturus using the ASTM standard and it will communicate electronically with CHCS using the HL7 standard. Delivery of this system will establish feasibility of the entire project. Additionally during Phase 1 the proposer will perform a comprehensive requirements analysis for Phase 2. Phase 2 deliverables will include DITSCAP accreditation and software validation as well all other deliverables identified in the requirements analysis proposed for Phase 1. Phase 2 deliverables may include a data management system, software for manual editing of instrument sample layout, configuration of the Triturus software, and analysis of the clinical trial data.

Principal Investigator:

Raymond J. Peterson
Chief Science Officer
3016832118
rpeterson@celadonlabs.com

Business Contact:

Lawrence A. Kessner
Chief Executive Officer
3016832117
lkessner@celadonlabs.com
Small Business Information at Submission:

CELADON LABORATORIES, INC.
6525 Belcrest RD Suite 500 Hyattsville, MD 20782

EIN/Tax ID: 522223222
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No